AbCellera Biologics Inc.: cashflow_financing
| Value | {"amount": -1958000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-06-30 |
| Status | current |
| Entity | AbCellera Biologics Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:26:08.451112+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c49efa51-7a01-4cdc-b3bc-ae24a6a169a1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-22-028784Retrieved: 2026-08-19T17:26:08.451112+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001703057/cashflow-financing/2022-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c49efa51-7a01-4cdc-b3bc-ae24a6a169a1
History
- no predecessors — first report